The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men

Clinical Endocrinology

Volumn 63, Issue 2, 2005, Pages 131-138

  Oh, Ki Won ^a   Lee, Won Young ^b   Rhee, Eun Jung ^b   Baek, Ki Hyun ^c   Yoon, Kun Ho ^c   Kang, Moo Il ^c   Yun, Eun Joo ^a   Park, Cheol Young ^a   Ihm, Sung Hee ^a   Choi, Moon Gi ^a   Yoo, Hyung Joon ^a   Park, Sung Woo ^a  

^a Hallym University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALKALINE PHOSPHATASE; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; CHOLESTEROL; CREATININE; ESTRADIOL; GHRELIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; RESISTIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BODY MASS; BONE DENSITY; CALCIUM BLOOD LEVEL; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ESTRADIOL BLOOD LEVEL; FEMUR NECK; GLUCOSE BLOOD LEVEL; HUMAN; LIPID METABOLISM; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TESTOSTERONE BLOOD LEVEL;

ADIPONECTIN; ADULT; AGE FACTORS; AGED; BODY MASS INDEX; BODY WEIGHT; BONE DENSITY; CHOLESTEROL; ESTRADIOL; FEMUR NECK; HORMONES, ECTOPIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PEPTIDE HORMONES; RESISTIN; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 23244450048     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02312.x     Document Type: Article

References (73)

1. Seeman, E., Melton, L.J. 3rd, O'Fallon, W.M. & Riggs, B.L. (1983) Risk factors for spinal osteoporosis in men. American Journal of Medicine, 75, 977-983.
2. Melton, L.J. 3rd, Kan, S.H., Frye, M.A., Wahner, H.W., O'Fallon, W.M. & Riggs, B.L. (1989) Epidemiology of vertebral fractures in women. American Journal of Epidemiology, 129, 1000-1011.
3. Pocock, N., Eisman, J., Gwinn, T., Sambrook, P., Kelly, P., Freund, J. & Yeates, M. (1989) Muscle strength, physical fitness, and weight but not age predict femoral neck bone mass. Journal of Bone and Mineral Research, 4, 441-448.
4. Slemenda, C.W., Hui, S.L., Longcope, C., Wellman, H. & Johnston, C.C. Jr. (1990) Predictors of bone mass in perimenopausal women. A prospective study of clinical data using photon absorptiometry. Annals of Internal Medicine, 112, 96-101.
5. Felson, D.T., Zhang, Y., Hannan, M.T. & Anderson, J.J. (1993) Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. Journal of Bone and Mineral Research, 8, 567-573.
6. Schindler, A.E., Ebert, A. & Friedrich, E. (1972) Conversion of androstenedione to estrone by human fat tissue. Journal of Clinical Endocrinology and Metabolism, 35, 627-630.
7. Slemenda, C.W., Longcope, C., Zhou, L., Hui, S.L., Peacock, M. & Johnston, C.C. (1997) Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. Journal of Clinical Investigation, 100, 1755-1759.
8. Khosla, S., Melton, L.J., Atkinson, E.J., O'Fallon, W.M., Klee, G.G. & Riggs, B.L. (1998) Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. Journal of Clinical Endocrinology and Metabolism, 83, 2266-2274.
9. Ongphiphadhanakul, B., Rajatanavin, R., Chanprasertyothin, S., Piaseu, N. & Chailurkit, L. (1998) Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clinical Endocrinology, 49, 803-809.
10. Hickman, J. & McElduff, A. (1989) Insulin promotes growth of the cultured rat osteosarcoma cell line UMR-106-01: an osteoblast-like cell. Endocrinology, 124, 701-706.
11. Reid, I.R., Evans, M.C., Cooper, G.J., Ames, R.W. & Stapleton, J. (1993) Circulating insulin levels are related to bone density in normal postmenopausal women. American Journal of Physiology, 265, 655-659.
12. Barrett-Connor, E. & Kritz-Silverstein, D. (1996) Does hyperinsulinemia preserve bone? Diabetes Care, 19, 1388-1392.
13. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Lori, L. & Friedman, J.M. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425-432.
14. Maffei, M., Halaas, J.L., Ravussin, E., Pratley, R.E., Lee, G.H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., Kern, P.A. & Friedman, J.M. (1995) Leptin levels in human and rodent. Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine, 1, 1155-1161.
15. Considine, R.V., Sinha, M.K., Heiman, M.L., Kriauciunas, A., Stephens, T.W., Nyce, M.R., Ohannesian, J.P., Marco, C.C., McKee, L.J., Bauer, T.L. & Caro, J.F. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New England Journal of Medicine, 334, 292-295.
16. Cinti, S., Frederich, R.C., Zingaretti, M.C., Dematteis, R., Flier, J.S. & Lowell, B.B. (1997) Immunohistochemical localization of leptin and uncoupling protein in white and brown adipose tissue. Endocrinology, 138, 797-804.
17. Thomas, T., Burguera, B., Melton, L.J. III, Atkinson, E.J., Riggs, B.L. & Khosla, S. (2000) Relationship of serum leptin levels with body composition, sex steroid, and insulin levels in women and men. Metabolism, 49, 1278-1284.
18. Thomas, T., Gori, F., Khosla, S., Jensen, M.D., Burguera, B. & Riggs, B.L. (1999) Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology, 140, 1630-1638.
19. Foldes, J., Shih, M.S. & Levy, J. (1992) Bone structure and calcium metabolism in obese Zucker rats. International Journal of Obesity, 16, 95-102.
20. Burguera, B., Hofbauer, L., Thomas, T., Gori, F., Lamsam, J., Laakso, K., Evans, G., Khosla, S., Riggs, B.L. & Turner, R. (2001) Leptin reduces ovariectomy-induced bone loss. Endocrinology, 142, 3546-3553.
21. Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A.F., Beil, F.T., Shen, J.H., Vinson, C., Rueger, J.M. & Karsenty, G. (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell, 100, 197-207.
22. Sato, M., Takeda, N., Sarui, H., Takami, R., Takami, K., Hayashi, M., Sasaki, A., Kawachi, S., Yoshino, K. & Yasuda, K. (2001) Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. Journal of Clinical Endocrinology and Metabolism, 86, 5273-5276.
23. Morberg, C.M., Tetens, I., Black, E., Toubro, S., Soerensen, T.I., Pedersen, O. & Astrup, A. (2003) Leptin and bone mineral density, a cross-sectional study in obese and nonobese men. Journal of Clinical Endocrinology and Metabolism, 88, 5795-5800.
24. Sun, A.J., Jing, T., Heymsfield, S.B. & Phillips, G.B. (2003) Relationship of leptin and sex hormones to bone mineral density in men. Acta Diabetologica, 40S1, S101-S105.
25. Zoico, E., Zamboni, M., Adami, S., Vettor, R., Mazzali, G., Tosoni, P., Bissoli, L. & Bosello, O. (2003) Relationship between leptin levels and bone mineral density in the elderly. Clinical Endocrinology, 59, 97-103.
26. Odabasi, E., Ozata, M., Turan, M., Bingol, N., Yonem, A., Cakir, B., Kutlu, M. & Ozdemir, I.C. (2000) Plasma leptin concentrations in postmenopausal women with osteoporosis. European Journal of Endocrinology, 142, 170-173.
27. Yamauchi, M., Sugimoto, T., Yamaguchi, T., Nakaoka, D., Kanzawa, M., Yano, S., Ozuru, R., Sugishita, T. & Chihara, K. (2001) Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clinical Endocrinology, 55, 341-347.
28. Hadji, P., Bock, K., Gotschalk, M., Hars, O., Backhus, J., Emons, G. & Schulz, K.D. (2003) The influence of serum leptin concentration on bone mass assessed by quantitative ultrasonometry in pre and postmenopausal women. Maturitas, 44, 141-148.
29. Roux, C., Arabi, A., Porcher, R. & Garnero, P. (2003) Serum leptin as a determinant of bone resorption in healthy postmenopausal women. Bone, 33, 847-852.
30. Shaarawy, M., Abassi, A.F., Hassan, H. & Salem, M.E. (2003) Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis. Fertility and Sterility, 79, 919-924.
31. Hamrick, M.W., Pennington, C., Newton, D., Xie, D. & Isales, C. (2004) Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone, 34, 376-383.
32. Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y. & Matsubara, K. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant GENE transcript 1). Biochemical and Biophysical Research Communications, 221, 286-289.
33. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., Kuriyama, H., Nishida, M., Yamashita, S., Okubo, K., Matsubara, K., Muraguchi, M., Ohmoto, Y., Funahashi, T. & Matsuzawa, Y. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications, 257, 79-83.
34. Matsubara, M., Maruoka, S. & Katayose, S. (2002) Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. European Journal of Endocrinology, 147, 173-180.
35. Diez, J.J. & Iglesias, P. (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. European Journal of Endocrinology, 148, 293-300.
36. Lenchik, L., Register, T.C., Hsu, F.C., Lohman, K., Nicklas, B.J., Freedman, B.I., Langefeld, C.D., Carr, J.J. & Bowden, D.W. (2003) Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone, 33, 646-651.
37. Steppan, C.M., Bailey, S.T., Bhat, S., Brown, E.J., Banerjee, R.R., Wright, C.M., Patel, H.R., Ahima, R.S. & Lazar, M.A. (2001) The hormone resistin links obesity to diabetes. Nature, 409, 307-312.
38. Holcomb, I.N., Kabakoff, R.C., Chan, B., Baker, T.W., Gurney, A., Henzel, W., Nelson, C., Lowman, H.B., Wright, B.D., Skelton, N.J., Frantz, G.D., Tumas, D.B., Peale, F.V. Jr, Shelton, D.L. & Hebert, C.C. (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO Journal, 19, 4046-4055.
39. McTernan, C.L., McTernan, P.G., Harte, A.L., Levick, P.L., Barnett, A.H. & Kumar, S. (2002) Resistin, central obesity, and type 2 diabetes. Lancet, 359, 46-47.
40. Hotamisligil, G.S. (2003) The irresistible biology of resistin. Journal of Clinical Investigation, 111, 173-174.
41. Rajala, M.W., Obici, S., Scherer, P.E. & Rossetti, L. (2003) Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. Journal of Clinical Investigation, 111, 225-230.
42. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H. & Kangawa, K. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402, 656-660.
43. Tschop, M., Smiley, D.L. & Heiman, M.L. (2000) Ghrelin induces adiposity in rodents. Nature, 407, 908-913.
44. Wren, A.M., Small, C.J., Ward, H.L., Murphy, K.G., Dakin, C.L., Taheri, S., Kennedy, A.R., Roberts, G.H., Morgan, D.G., Ghatei, M.A. & Bloom, S.R. (2000) The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology, 141, 4325-4328.
45. Tschop, M., Weyer, C., Tataranni, P.A., Devanarayan, V., Ravussin, E. & Heiman, M.L. (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes, 50, 707-709.
46. Cummings, D.E., Weigle, D.S., Frayo, R.S., Breen, P.A., Ma, M.K., Dellinger, E.P. & Purnell, J.Q. (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New England Journal of Medicine, 346, 1623-1630.
47. Hansen, T.K., Dall, R., Hosoda, H., Kojima, M., Kangawa, K., Christiansen, J.S. & Jorgensen, J.O. (2002) Weight loss increases circulating levels of ghrelin in human obesity. Clinical Endocrinology, 56, 203-206.
48. Shiiya, T., Nakazato, M., Mizuta, M., Date, Y., Mondal, M.S., Tanaka, M., Nozoe, S., Hosoda, H., Kangawa, K. & Matsukura, S. (2002) Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. Journal of Clinical Endocrinology and Metabolism, 87, 240-244.
49. Coates, P.S., Fernstrom, J.D., Fernstrom, M.H., Schauer, P.R. & Greenspan, S.L. (2004) Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. Journal of Clinical Endocrinology and Metabolism, 89, 1061-1065.
50. WHO Western Pacific Region, IASO and IOTF (2000) The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Health Communications Australia Pty Limit, Sydney, Australia.
51. Ruhl, C.E. & Everhart, J.E. (2002) Relationship of serum leptin concentration with bone mineral density in the United States population. Journal of Bone and Mineral Research, 17, 1896-1903.
52. Kontogianni, M.D., Dafni, U.G., Routsias, J.G. & Skopouli, F.N. (2004) Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. Journal of Bone and Mineral Research, 19, 546-551.
53. Yokota, T., Meka, C.S., Medina, K.L., Igarashi, H., Comp, P.C., Takahashi, M., Nishida, M., Oritani, K., Miyagawa, J., Funahashi, T., Tomiyama, Y., Matsuzawa, Y. & Kincade, P.W. (2002) Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. Journal of Clinical Investigation, 109, 1303-1310.
54. Fujimori, A., Tsutsumi, M., Fukase, M. & Fujita, T. (1989) Cyclooxygenase inhibitors enhance cell growth in an osteoblastic cell line, MC3T3-E1. Journal of Bone and Mineral Research, 4, 697-704.
55. Zhang, X., Schwarz, E.M., Young, D.A., Puzas, J.E., Rosier, R.N. & O'Keefe, R.J. (2002) Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. Journal of Clinical Investigation, 109, 1405-1415.
56. Way, J.M., Gorgun, C.Z., Tong, Q., Uysal, K.T., Brown, K.K., Harrington, W.W., Oliver, W.R. Jr, Willson, T.M., Kliewer, S.A. & Hotamisligil, G.S. (2001) Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. Journal of Biological Chemistry, 276, 25651-25653.
57. Song, H., Shojima, N., Sakoda, H., Ogihara, T., Fujishiro, M., Katagiri, H., Anai, M., Onishi, Y., Ono, H., Inukai, K., Fukushima, Y., Kikuchi, M., Shimano, H., Yamada, N., Oka, Y. & Asano, T. (2002) Resistin is regulated by C/EBPs, PPARs, and signal-transducing molecules. Biochemical and Biophysical Research Communications, 299, 291-298.
58. Patel, L., Buckels, A.C., Kinghorn, I.J., Murdock, P.R., Holbrook, J.D., Plumpton, C., Macphee, C.H. & Smith, S.A. (2003) Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochemical and Biophysical Research Communications, 300, 472-476.
59. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S. & Marshak, D.R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147.
60. Lecka-Czernik, B., Gubrij, I., Moerman, E.J., Kajkenova, O., Lipschitz, D.A., Manolagas, S.C. & Jilka, R.L. (1999) Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. Journal of Cellular Biochemistry, 74, 357-371.
61. Lecka-Czernik, B., Moerman, E.J., Grant, D.F., Lehmann, J.M., Manolagas, S.C. & Jilka, R.L. (2002) Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology, 143, 2376-2384.
62. Okazaki, R., Miura, M., Toriumi, M., Taguchi, M., Hirota, Y., Fukumoto, S., Fujita, T., Tanaka, K. & Takeuchi, A. (1999) Short-term treatment with troglitazone decreases bone turnover in patients with type 2 diabetes mellitus. Endocrine Journal, 46, 795-801.
63. Watanabe, S., Takeuchi, Y., Fukumoto, S., Fujita, H., Nakano, T. & Fujita, T. (2003) Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients. Journal of Bone Mineral and Metabolism, 21, 166-171.
64. Lehto-Axtelius, D., Chen, D., Surve, V.V. & Hakanson, R. (2002) Post-gastrectomy osteopenia in the rat: bone structure is preserved by retaining 10%-30% of the oxyntic gland area. Scandinavian Journal of Gastroenterology, 37, 437-443.
65. Maccarinelli, G., Sibilia, V., Torsello, A., Raimondo, F., Pitto, M., Giustina, A., Netti, C. & Cocchi, D. (2005) Ghrelin regulates proliferation and differentiation of osteoblastic cells. Journal of Endocrinology, 184, 249-256.
66. Szulc, P., Munoz, F., Claustrat, B., Garnero, P., Marchand, F., Duboeuf, F. & Delmas, P.D. (2001) Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. Journal of Clinical Endocrinology and Metabolism, 86, 192-199.
67. Martinez Diaz-Guerra, G., Hawkins, F., Rapado, A., Ruiz Diaz, M.A. & Diaz-Curiel, M. (2001) Hormonal and anthropometric predictors of bone mass in healthy elderly men. major effect of sex hormone binding globulin, parathyroid hormone and body weight. Osteoporosis International, 12, 178-184.
68. Greendale, G.A., Edelstein, S. & Barrett-Connor, E. (1997) Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo study. Journal of Bone and Mineral Research, 12, 1833-1843.
69. Tsai, E.C., Matsumoto, A.M., Fujimoto, W.Y. & Boyko, E.J. (2004) Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care, 27, 861-868.
70. Bendavid, E.J., Shan, J. & Barrett-Connor, E. (1996) Factors associated with bone mineral density in middle-aged men. Journal of Bone and Mineral Research, 11, 1185-1190.
71. Hannan, M.T., Felson, D.T., Dawson-Hughes, B., Tucker, K.L., Cupples, L.A., Wilson, P.W. & Kiel, D.P. (2000) Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. Journal of Bone and Mineral Research, 15, 710-720.
72. Rhee, E.J., Oh, K.W., Lee, W.Y., Kim, S.W., Oh, E.S., Back, K.H., Kang, M.I., Park, C.Y., Choi, M.G., Yoo, H.J. & Park, S.W. (2004) Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men. Journal of Bone and Mineral Metabolism, 22, 392-398.
73. May, H., Murphy, S. & Khaw, K.T. (1995) Alcohol consumption and bone mineral density in older men. Gerontology, 41, 152-158.